Does the Duration of the Illness Affect the Severity of Negative Symptoms of Schizophrenia?

Overview

Journal Mater Sociomed

Date 2022 Jul 8

PMID 35801060

Authors

Nejra Becarevic

Rusmir Softic

Enes Osmanovic

Affiliations

Soon will be listed here.

Abstract

Background: The negative symptoms of schizophrenia are less known aspects of the illness although they often mark its course and outcome. Negative symptoms refer to loss of function, and they are associated with poor outcomes. It is considered that they are more prominent with the longer duration of illness.

Objective: To determine the negative symptoms in the patients with schizophrenia with regard to the duration of illness.

Methods: A cross-sectional study was conducted in 60 consecutive outpatients with schizophrenia. Two groups were formed regarding the duration of illness (⩽2 years, and >3 years). The negative symptoms were established with the Brief Negative Symptom Assessment - BNSA.

Results: Average score of negative symptoms in the group with the shorter duration of illness was 8.37±2.94, and in the group with longer duration was 10.73±2.86. Independent Samples Test was significant p=0.003, t-2.367, and therefore the difference between scores on BNSA within groups was significant. Moderate size effect was found (p = 0.69).

Conclusion: Negative symptoms of schizophrenia are more prominent with the longer duration of illness.

Citing Articles

Predictors of Psychosocial Functioning Among Long-stay Schizophrenia Patients in a Malaysian Mental Institution.

Teo P, Koh E, Chong S Malays J Med Sci. 2025; 31(6):178-193.

PMID: 39830103 PMC: 11740817. DOI: 10.21315/mjms2024.31.6.14.

Comparison between olanzapine and aripiprazole treatment for 104 weeks after hospital discharge in schizophrenia spectrum disorders: a multicenter retrospective cohort study in a real-world setting.

Hosokawa T, Miyaji C, Yoshimura Y, Washida K, Yada Y, Sakamoto S Psychopharmacology (Berl). 2023; 240(9):1911-1920.

PMID: 37460628 DOI: 10.1007/s00213-023-06407-6.

High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders.

Auxilia A, Buoli M, Caldiroli A, Carnevali G, Tringali A, Nava R Biomedicines. 2023; 11(2).

PMID: 36830850 PMC: 9953565. DOI: 10.3390/biomedicines11020314.

References

Correll C, Schooler N . Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. Neuropsychiatr Dis Treat. 2020; 16:519-534. PMC: 7041437. DOI: 10.2147/NDT.S225643. View

Ang M, Rekhi G, Lee J . Validation of the Brief Negative Symptom Scale and its association with functioning. Schizophr Res. 2019; 208:97-104. DOI: 10.1016/j.schres.2019.04.005. View

Mitra S, Mahintamani T, Kavoor A, Nizamie S . Negative symptoms in schizophrenia. Ind Psychiatry J. 2017; 25(2):135-144. PMC: 5479085. DOI: 10.4103/ipj.ipj_30_15. View

Kirkpatrick B, Strauss G, Nguyen L, Fischer B, Daniel D, Cienfuegos A . The brief negative symptom scale: psychometric properties. Schizophr Bull. 2010; 37(2):300-5. PMC: 3044634. DOI: 10.1093/schbul/sbq059. View

Rabinowitz J, Werbeloff N, Caers I, Mandel F, Stauffer V, Menard F . Negative symptoms in schizophrenia--the remarkable impact of inclusion definitions in clinical trials and their consequences. Schizophr Res. 2013; 150(2-3):334-8. DOI: 10.1016/j.schres.2013.06.023. View

Bobes J, Arango C, Garcia-Garcia M, Rejas J . Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J Clin Psychiatry. 2009; 71(3):280-6. DOI: 10.4088/JCP.08m04250yel. View

Pogue-Geile M, Harrow M . Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Schizophr Bull. 1985; 11(3):427-39. DOI: 10.1093/schbul/11.3.427. View

Thara R, Henrietta M, Joseph A, Rajkumar S, Eaton W . Ten-year course of schizophrenia--the Madras longitudinal study. Acta Psychiatr Scand. 1994; 90(5):329-36. DOI: 10.1111/j.1600-0447.1994.tb01602.x. View

Lindenmayer J, Kay S, Friedman C . Negative and positive schizophrenic syndromes after the acute phase: a prospective follow-up. Compr Psychiatry. 1986; 27(4):276-86. DOI: 10.1016/0010-440x(86)90003-9. View

10.

Kulhara P, Chandiramani K . Positive and negative subtypes of schizophrenia. A follow-up study from India. Schizophr Res. 1990; 3(2):107-16. DOI: 10.1016/0920-9964(90)90043-7. View

11.

Austin S, Mors O, Budtz-Jorgensen E, Secher R, Hjorthoj C, Bertelsen M . Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10year follow-up study in the OPUS cohort. Schizophr Res. 2015; 168(1-2):84-91. DOI: 10.1016/j.schres.2015.07.021. View

12.

Foussias G, Agid O, Fervaha G, Remington G . Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders. Eur Neuropsychopharmacol. 2013; 24(5):693-709. DOI: 10.1016/j.euroneuro.2013.10.017. View

13.

Ventura J, Subotnik K, Gitlin M, Gretchen-Doorly D, Ered A, Villa K . Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later. Schizophr Res. 2014; 161(2-3):407-13. PMC: 4308531. DOI: 10.1016/j.schres.2014.10.043. View